Why is Pfizer's rollout of its anti-COVID pill so slow?

Pfizer's antiviral COVID-19 pill for at-risk people aged 12 and above has been authorised in the US.

Source: AAP

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus.But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.


LISTEN TO
Why is Pfizer's rollout of its anti-COVID pill so slow? image

फाइजरको कोभिड-१९ ट्याब्लेट बजारमा आउन किन समय लागिरहेको छ?

SBS Nepali

05:59

Share